Eat Just will start offering lab-grown chicken meat in Singapore after gaining regulatory approval from the Singapore Food Agency (SFA). The cell-cultured chicken will eventually be produced under Eat Just’s new GOOD Meat brand through partnerships with local manufacturers and go on sale to restaurants before it is available to consumers.
While there are plenty of other companies working on lab-grown meats using various techniques, Eat Just describes the Singapore government’s review and regulatory approval as a “world first.”
No chickens were killed to obtain the cell line used to produce Eat Just’s cultured meat, global head of communications Andrew Noyes told TechCrunch. Instead, the process starts with cell isolation, where cells are sourced through methods that can include a biopsy from a live animal. After the cells are cultured, they are transferred into a bioreactor, fed with a proprietary mix of proteins, amino acids, minerals, sugars, salts and other nutrients and then harvested after they achieve enough density.
The company said it went through 20 production runs of cell-cultured chicken in 1,200-liter bioreactors to prove the consistency of its manufacturing process. Eat Just also said no antibiotics were used and that its cultured chicken has an “extremely low and significantly cleaner microbiological content than conventional chicken.”
Noyes said the company is already working with a restaurant to add its GOOD Meat chicken to their menu, and hopes to announce a launch date soon.
In Eat Just’s announcement today, chief executive officer Josh Tetrick said, “Singapore has long been a leader in innovation of all kinds, from information technology to biologics to now leading the world in building a healthier, safer food system.”
The government is currently engaged in an initiative, called “30 by 30,” to produce 30% of the country’s food supply locally by 2030. Spearheaded by the Singapore Food Agency (SFA), the initiative was prompted because Singapore currently imports over 90% of its food, which makes it vulnerable to export bans or the logistics issues highlighted by the COVID-19 pandemic’s impact. As part of “30 by 30,” the SFA and Agency for Science, Technology and Research has made $144 million SGD in research funding available.
Eat Just, whose other products include a plant-based egg substitute, announced last month it is partnering with Proterra Investment Partners Asia to launch a new Asian subsidiary. The partnership includes a factory in Singapore that received support from the government’s Economic Development board.
There are several factors driving demand for cultured meat and plant-based protein in Asian markets. The first is concern about the safety of meat from slaughterhouses that gained momentum during the COVID-19 pandemic. The pandemic also highlighted vulnerabilities in the production and supply chain that can potentially be avoided with lab-produced meat and meat alternatives.